These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction. Kang MJ; Lee SY; Kim HB; Yu J; Kim BJ; Choi WA; Jang SO; Hong SJ Pharmacogenet Genomics; 2008 Jul; 18(7):551-8. PubMed ID: 18551035 [TBL] [Abstract][Full Text] [Related]
44. [Measurement of cytokines in patients with exercise-induced asthma treated with anti-leukotrienes]. Flores Sandoval G; Orea Solano M; Cortés Padilla V; Santos Argumedo L Rev Alerg Mex; 2002; 49(5):143-8. PubMed ID: 12501759 [TBL] [Abstract][Full Text] [Related]
45. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group. Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612 [TBL] [Abstract][Full Text] [Related]
46. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. Findlay SR; Barden JM; Easley CB; Glass M J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246 [TBL] [Abstract][Full Text] [Related]
47. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction. Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203 [TBL] [Abstract][Full Text] [Related]
48. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176 [TBL] [Abstract][Full Text] [Related]
49. Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. Shimizu T; Mochizuki H; Shigeta M; Morikawa A Am J Respir Crit Care Med; 1997 Jan; 155(1):170-3. PubMed ID: 9001307 [TBL] [Abstract][Full Text] [Related]
50. Management of asthma with zafirlukast. Clinical experience and tolerability profile. Spector SL Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219. Smith LJ; Glass M; Minkwitz MC Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486 [TBL] [Abstract][Full Text] [Related]
52. The effect of body posture during medication inhalation on exercise induced bronchoconstriction in asthmatic children. Visser R; Wind M; de Graaf BJ; de Jongh FH; van der Palen J; Thio BJ Respir Med; 2015 Oct; 109(10):1257-61. PubMed ID: 26341547 [TBL] [Abstract][Full Text] [Related]
53. Review of recent results of montelukast use as a monotherapy in children with mild asthma. Wahn U; Dass SB Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477 [TBL] [Abstract][Full Text] [Related]
54. Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma. Dempsey OJ; Fowler SJ; Wilson A; Kennedy G; Lipworth BJ Chest; 2002 Jul; 122(1):151-9. PubMed ID: 12114351 [TBL] [Abstract][Full Text] [Related]
55. New insights into treatment of children with exercise-induced asthma symptoms. Stelmach I; Sztafiska A; Jerzyska J; Podlecka D; Majak P; Stelmach W Allergy Asthma Proc; 2016 Nov; 37(6):466-474. PubMed ID: 27931302 [TBL] [Abstract][Full Text] [Related]
56. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. Coreno A; Skowronski M; Kotaru C; McFadden ER J Allergy Clin Immunol; 2000 Sep; 106(3):500-6. PubMed ID: 10984370 [TBL] [Abstract][Full Text] [Related]
57. Effects of exercise training and montelukast in children with mild asthma. Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200 [TBL] [Abstract][Full Text] [Related]
58. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246 [TBL] [Abstract][Full Text] [Related]
59. Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction. Storm van's Gravesande K; Mattes J; Grossklauss E; Zurmühl A; Moseler M; Kühr J Eur J Pediatr; 2000 Oct; 159(10):759-63. PubMed ID: 11039131 [TBL] [Abstract][Full Text] [Related]
60. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]